United Therapeutics
UTHR
$223.68
Share price
-0.11%
Change (1 day)
-2.12%
Change (1 year)
Categories
United Therapeutics (UTHR) - Total debt
Total debt on the balance sheet as of March 2023 : $0.80 B
According to United Therapeutics's latest financial reports the company's total debt is $0.80 B. A company’s total debt is the sum of all current and non-current debts.
United Therapeutics - Total debt on balance sheet (from 2001 to 2023)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2022-12-31 | $0.80 B | 0% |
| 2021-12-31 | $0.80 B | 0% |
| 2020-12-31 | $0.80 B | -5.88% |
| 2019-12-31 | $0.85 B | 240% |
| 2018-12-31 | $0.25 B | 0% |
| 2017-12-31 | $0.25 B | |
| 2015-12-31 | $5.38 M | -95.74% |
| 2014-12-31 | $0.12 B | -55.8% |
| 2013-12-31 | $0.28 B | 4.06% |
| 2012-12-31 | $0.27 B | 41.63% |
| 2011-12-31 | $0.19 B | -36.31% |
| 2010-12-31 | $0.30 B | 21.67% |
| 2009-12-31 | $0.25 B | -10.26% |
| 2008-12-31 | $0.27 B | 11.69% |
| 2007-12-31 | $0.25 B | -0% |
| 2006-12-31 | $0.25 B | 1086965.22% |
| 2005-12-31 | $0.02 M | -11.54% |
| 2004-12-31 | $0.02 M | -96.74% |
| 2003-12-31 | $0.79 M | -57.51% |
| 2002-12-31 | $1.87 M | -3.11% |
| 2001-12-31 | $1.93 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | $34.92 B | 4,265.88% | 🇺🇸 USA |
 Eli Lilly LLY | $18.82 B | 2,252.50% | 🇺🇸 USA |
 Baxter BAX | $16.92 B | 2,015.13% | 🇺🇸 USA |
 Gilead Sciences GILD | $25.23 B | 3,054.88% | 🇺🇸 USA |
 Cardinal Health CAH | $4.70 B | 487.63% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $27.08 B | 3,286.09% | 🇬🇧 UK |
 Cytokinetics
CYTK | $0.74 B | -6.34% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | $21.01 B | 2,527.00% | 🇮🇱 Israel |